4502:TYO
Takeda Pharmaceutical Company
6.627,00 JPY
arrow_downward
−0,69%(−46,00) 1D
10. stu, 09:10:01 GMT+9 · JPY
search
Svi simboli
| Simbol | Cijena | Promjena | Postotna promjena |
|---|
insights_autoGeneriranje najvažnijih uvida za 4502...
Otvori
6.606 JPY
Najviša
6.636 JPY
Najniža
6.592 JPY
Trž. kap.
10,61 bil.
Prosj. kol.
4,87 mil.
Količina
417,00 tis.
Dividenda
3,05 %
Kvartalna dividenda
50 JPY
Datum nakon isplate dividende
29. ruj 2026.
P/E omjer
316,48
52-tjed. najviša
6.989 JPY
52-tjed. najniža
4.172 JPY
EPS
21 JPY
Dionice u optjecaju
784,48 mil.
Broj djelatnika
47 tis.
Otvori
6.606 JPY
Najviša
6.636 JPY
Najniža
6.592 JPY
Trž. kap.
10,61 bil.
Prosj. kol.
4,87 mil.
Količina
417,00 tis.
Dividenda
3,05 %
Kvartalna dividenda
50 JPY
Datum nakon isplate dividende
29. ruj 2026.
P/E omjer
316,48
52-tjed. najviša
6.989 JPY
52-tjed. najniža
4.172 JPY
EPS
21 JPY
Dionice u optjecaju
784,48 mil.
Broj djelatnika
47 tis.
Vijesti
Iz web-izvora i od partnera za vijesti
Bloomberg.com
·
prije 2 sata
Watch S&P 500 Erases Midterm Losses, Bitcoin Bounce
Investing.com
·
prije 2 sata
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 2.15%
ChartMill
·
prije 5 sati
Most-Active S&P 500 Stocks in Today's Session
StoneX
·
prije 7 sati
S&P 500 Forecast: SPX rises despite Nvidia’s decline
Profil
The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company. It is the third largest pharmaceutical company in Asia, behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by revenue. The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies and vaccines. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States. As of 2015, Christophe Weber was appointed as the CEO and president of Takeda. In 2026, Julie Kim was noted in a news item as "CEO-elect". Wikipedia
Takeda Pharmaceutical Company – informacije
Glavni izvršni direktorChristophe Weber | Christophe Weber
Zaposlenici47 tis.
Osnovano12. lip 1781.
Sjedište-
SektorHealth Care
Djelatnost-
Web-lokacijatakeda.com